Last reviewed · How we verify
NCT03339011
Digital Motivation to Decrease Inactive Behaviour in Patients With Knee Osteoarthritis
NA trial testing Motivational SMS text message in Knee Osteoarthritis in 38 participants. Completed in 29 July 2018.
29 July 2018
Quick facts
| Lead sponsor | Marius Henriksen |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 38 |
| Start date | 14 November 2017 |
| Primary completion | 29 July 2018 |
| Estimated completion | 29 July 2018 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Motivational SMS text message
Conditions studied
- Knee Osteoarthritis — all drugs for Knee Osteoarthritis →
Sponsor
Marius Henriksen — full company profile →
Who can join
18 and older, any sex, with Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Physical inactivity is a major risk behaviour with a potential for causing premature death, particularly among people with mobility limitations, such as knee osteoarthritis. Digital motivational interventions (such as SMS) can motive to a healthy behaviour including increased physical activity. The purpose of this study is to investigate if motivational text messages following an exercise intervention to improve mobility limitations will change the physical activity level in patients with knee osteoarthritis. This study is designed as pilot randomized controlled trial, with equal randomization (1:1). Eligible participants will be randomised into one of two groups (intervention or control) after completing their baseline measurements. The intervention group will receive weekly motivational text messages and the control group will not receive any attention from the study.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effectiveness of text messages for decreasing inactive behaviour in patients with knee osteoarthritis: a pilot randomised controlled study.
Bartholdy C, Bliddal H, Henriksen M. · · 2019 · cited 10× · PMID 31516729 · DOI 10.1186/s40814-019-0494-6
Verify or expand the search:
- PubMed search for NCT03339011
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Knee Osteoarthritis
Currently open trials in the same condition.
- NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
- NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
- NCT07370480 — Knee Osteoarthritis and Thermal Spa Treatment · NA · recruiting
- NCT07507175 — Gastrocnemius Myofascial Release in Females With Knee Osteoarthritis · NA · recruiting
- NCT07386600 — Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA · NA · recruiting
Other Marius Henriksen trials
Trials by the same sponsor.
- NCT07210931 — Self-managed vs Supervised Exercise for Knee OA · NA · not yet recruiting
- NCT06846008 — The Effectiveness of a Coach-Focused Intervention on Preventing Knee Injuries in Amateur Football Players · NA · completed
- NCT05215678 — Characteristics of Patients Declining INKA Trial Participation · completed
- NCT05172843 — Intensive Diet vs Knee Arthroplasty for Knee Osteoarthritis · NA · completed
- NCT04729179 — Cannabidiol for Fibromyalgia (The CANNFIB Trial) · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03339011 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Marius Henriksen
- Last refreshed: 2 August 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03339011.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing